On September 15, 2026, Glass Lewis announced that it was soliciting public comment on four research perspectives that will underpin its new research model that will be introduced in September 2027. As previously announced in October 2025, starting in 2027, Glass Lewis will begin offering more bespoke voting advice that will offer multiple perspectives so
Ali Perry
SEC Proposes Modernization of Proxy Solicitation Rules
On September 16, 2026, the Securities and Exchange Commission (the “SEC”) proposed amendments to modernize the proxy solicitation rules (Release Nos. 33-11439; 34-106385; File No. S7-2026-33) under Regulation 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which govern how companies and others solicit proxies to vote at shareholder meetings. Many…
SEC Proposes to Rescind Rule 14a-8: Another Nail in the Coffin for Shareholder Proposals?
In an awaited but not surprising proposing release, on September 16, 2026, the Securities and Exchange Commission (the “SEC” or the “Commission”) proposed rescinding Rule 14a-8 under the Securities Exchange Act of 1934, as amended, which governs the processes under which a shareholder may include a proposal in a public company’s proxy materials. The SEC…
SEC Proposes Rules Rescinding Federal Regulation of Shareholder Proposals and Modernizing Proxy Solicitations
On September 16, 2026, the Securities and Exchange Commission (the “Commission”) proposed two sets of amendments to the federal proxy rules under Regulation 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The first proposal would rescind Exchange Act Rule 14a-8, the shareholder proposal rule, and amend Exchange Act Rule 14a-4(c)…
SEC and FDA Enter Into Memorandum of Understanding to Enhance Interagency Cooperation
On August 31, 2026, the Securities and Exchange Commission announced that it entered into a Memorandum of Understanding (“MOU”) with the Food and Drug Administration (“FDA”) to create a framework to support the exchange of information between the two agencies regarding FDA-regulated products and activities. The MOU is designed to enhance both agencies’ ability to…
SEC Filing Fees are Decreasing to $87.00 per million dollars!
On August 21, 2026, the Securities and Exchange Commission (“SEC”) announced that the filing fee rate for securities registration will be decreasing from $138.10 per million dollars to $87.00 per million dollars, effective October 1, 2026. This is the second consecutive year that the filing fee has decreased in recent years.
The SEC filing fee…
FASB Proposes New Guidance on Stablecoin Classification as Cash Equivalents and Enhanced Disclosure Requirements
On August 18, 2026, the Financial Accounting Standards Board (“FASB”) issued a proposed accounting standards update (“ASU”) titled Statement of Cash Flows (Topic 230): Cash Equivalents—Disclosure Enhancement and Evaluation of Certain Digital Assets. The proposed ASU seeks to clarify whether certain digital assets meet the definition of “cash equivalents” on the balance sheet, and to…
NYSE Proposes Extending Internal Audit Function Transition Period from One Year to Five Years
On August 13, 2026, the Securities and Exchange Commission (“SEC”) published notice of a proposed rule change (SR-NYSE-2026-37) by the New York Stock Exchange (“NYSE”) to amend Sections 303A.00 and 303A.07 of the NYSE Listed Company Manual to extend the transition period in which a newly listed company must establish an internal audit…
SEC Stays Nasdaq’s New $5 Million MVLS Listing Standard Pending Commission Review
On July 29, 2026, the Securities and Exchange Commission (“SEC”) announced that it stayed its July 22, 2026 order (Release No. 34-105971) approving The Nasdaq Stock Market LLC’s (“Nasdaq’s”) rule proposal to adopt a new continued listing standard requiring listed companies to maintain a minimum Market Value of Listed Securities (“MVLS”) of at…
ESG and Anti-ESG Shareholder Proposals in 2026
In many ways, the 2026 proxy season has been markedly different than prior seasons, due, in no small part, to the November 2025 decision by the U.S. Securities and Exchange Commission (“SEC”) Staff not to provide substantive guidance on the grounds on which a company could omit a shareholder proposal under most prongs of Rule…
